Overview
Ken Maes practices in Brussels, Belgium. Mr. Maes is rated as a Distinguished expert by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Osteolysis Syndrome Recessive, Mantle Cell Lymphoma (MCL), and Delayed Growth.
His clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 35 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaMr. Maes isDistinguished. Learn about Multiple Myeloma.
- Experienced
- B-Cell LymphomaMr. Maes isExperienced. Learn about B-Cell Lymphoma.
- Delayed GrowthMr. Maes isExperienced. Learn about Delayed Growth.
- Li-Fraumeni SyndromeMr. Maes isExperienced. Learn about Li-Fraumeni Syndrome.
- Mantle Cell Lymphoma (MCL)Mr. Maes isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Osteolysis Syndrome RecessiveMr. Maes isExperienced. Learn about Osteolysis Syndrome Recessive.
- Precocious PubertyMr. Maes isExperienced. Learn about Precocious Puberty.